Axsome Therapeutics, Inc. (AXSM) vs Cytokinetics, Incorporated (CYTK)
- Axsome Therapeutics, Inc. AXSM 157.14 −2.87%
- Cytokinetics, Incorporated CYTK 61.95 −3.08%
Axsome Therapeutics, Inc. and Cytokinetics, Incorporated are both Biotechnology companies. Axsome Therapeutics, Inc. and Cytokinetics, Incorporated are of similar size ($8.9B and $8.5B). Axsome Therapeutics, Inc. grew revenue faster over the last twelve months: 56.9% against −21.1%. Axsome Therapeutics, Inc. has the higher net margin (−24.7% vs −1,321.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Axsome Therapeutics, Inc. leads on 11 and Cytokinetics, Incorporated on 4.
Valuation
Profitability
| Metric | AXSM | CYTK | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.24% | 87.97% | 65.16% |
| Operating margin | (23.96%) | (1,046.12%) | 0.00% |
| Net margin | (24.68%) | (1,321.12%) | 0.00% |
| Free cash flow margin | (9.27%) | (858.16%) | 0.00% |
| Return on equity | (245.10%) | 329.76% | (56.36%) |
| Return on assets | (27.35%) | (56.76%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack